Emerald Advisers LLC trimmed its stake in Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 99.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 345 shares of the financial services provider's stock after selling 87,238 shares during the quarter. Emerald Advisers LLC's holdings in Houlihan Lokey were worth $55,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the stock. Allspring Global Investments Holdings LLC boosted its position in Houlihan Lokey by 38.4% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,627 shares of the financial services provider's stock worth $850,000 after acquiring an additional 1,837 shares during the last quarter. Norden Group LLC purchased a new stake in shares of Houlihan Lokey in the first quarter valued at $834,000. Van ECK Associates Corp increased its stake in Houlihan Lokey by 36.5% in the first quarter. Van ECK Associates Corp now owns 19,506 shares of the financial services provider's stock valued at $2,500,000 after purchasing an additional 5,217 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in Houlihan Lokey during the first quarter worth about $2,844,000. Finally, Janney Montgomery Scott LLC acquired a new stake in Houlihan Lokey in the 1st quarter worth about $306,000. Institutional investors and hedge funds own 78.07% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on HLI. Wells Fargo & Company started coverage on shares of Houlihan Lokey in a research report on Thursday, September 12th. They issued an "underweight" rating and a $149.00 target price on the stock. Morgan Stanley upped their price objective on Houlihan Lokey from $146.00 to $163.00 and gave the stock an "equal weight" rating in a report on Monday, September 23rd. Keefe, Bruyette & Woods reiterated a "market perform" rating and issued a $154.00 target price (up previously from $139.00) on shares of Houlihan Lokey in a report on Wednesday, July 31st. UBS Group upped their price target on Houlihan Lokey from $170.00 to $190.00 and gave the stock a "buy" rating in a research note on Tuesday, October 8th. Finally, JPMorgan Chase & Co. reduced their price objective on Houlihan Lokey from $132.00 to $129.00 and set a "neutral" rating on the stock in a research note on Wednesday, July 31st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Houlihan Lokey presently has a consensus rating of "Hold" and an average target price of $157.00.
Read Our Latest Research Report on HLI
Insiders Place Their Bets
In other news, Chairman Scott L. Beiser sold 8,317 shares of the company's stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $151.89, for a total value of $1,263,269.13. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Houlihan Lokey news, Director Gillian Beth Zucker sold 200 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total transaction of $30,498.00. Following the sale, the director now directly owns 7,001 shares of the company's stock, valued at approximately $1,067,582.49. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Scott L. Beiser sold 8,317 shares of the firm's stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $151.89, for a total transaction of $1,263,269.13. The disclosure for this sale can be found here. Insiders sold a total of 9,917 shares of company stock valued at $1,513,129 in the last ninety days. Corporate insiders own 23.68% of the company's stock.
Houlihan Lokey Stock Performance
Shares of NYSE HLI traded down $0.89 during midday trading on Monday, reaching $170.42. 257,276 shares of the company's stock were exchanged, compared to its average volume of 321,992. The stock has a market capitalization of $11.85 billion, a PE ratio of 34.85 and a beta of 0.65. Houlihan Lokey, Inc. has a 52-week low of $100.92 and a 52-week high of $175.73. The business's fifty day moving average price is $160.96 and its two-hundred day moving average price is $145.86.
Houlihan Lokey (NYSE:HLI - Get Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.31 by $0.15. The company had revenue of $574.96 million for the quarter, compared to analyst estimates of $537.93 million. Houlihan Lokey had a return on equity of 19.29% and a net margin of 15.77%. Houlihan Lokey's quarterly revenue was up 23.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.11 EPS. Analysts predict that Houlihan Lokey, Inc. will post 5.7 earnings per share for the current fiscal year.
Houlihan Lokey Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, December 15th. Shareholders of record on Monday, December 2nd will be paid a dividend of $0.57 per share. The ex-dividend date is Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a yield of 1.34%. Houlihan Lokey's dividend payout ratio (DPR) is 46.63%.
Houlihan Lokey Company Profile
(
Free Report)
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Read More
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.